PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,521,000 | -7.1% | 94,000 | -6.0% | 0.53% | -0.4% |
| Q2 2019 | $2,713,000 | -21.8% | 100,000 | 0.0% | 0.53% | -24.4% |
| Q1 2019 | $3,469,000 | +493.0% | 100,000 | +233.3% | 0.70% | +309.9% |
| Q4 2018 | $585,000 | -12.0% | 30,000 | +20.0% | 0.17% | +44.5% |
| Q3 2018 | $665,000 | -86.1% | 25,000 | -80.3% | 0.12% | -87.1% |
| Q2 2018 | $4,797,000 | +30.0% | 127,000 | +12.4% | 0.92% | -27.1% |
| Q1 2018 | $3,691,000 | +8.3% | 113,000 | +61.4% | 1.26% | -4.0% |
| Q4 2017 | $3,408,000 | +8.7% | 70,000 | +20.7% | 1.32% | +46.3% |
| Q3 2017 | $3,134,000 | +458.6% | 58,000 | +110.9% | 0.90% | +165.5% |
| Q1 2016 | $561,000 | -83.5% | 27,500 | -58.3% | 0.34% | -80.6% |
| Q4 2015 | $3,396,000 | -37.8% | 66,000 | -48.4% | 1.75% | -34.7% |
| Q3 2015 | $5,456,000 | +22.2% | 128,000 | +30.6% | 2.68% | +33.1% |
| Q2 2015 | $4,464,000 | +32.1% | 98,000 | +10.1% | 2.01% | -10.9% |
| Q1 2015 | $3,379,000 | – | 89,000 | – | 2.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |